| Tarsons Products Ltd | Industry : (Healthcare) | |
|---|---|---|
|
BSE Code : 543399 |
NSE Symbol : TARSONS |
P/E(TTM) : 36.76 |
|
ISIN Demat : INE144Z01023 |
Div & Yield% : 0.00 |
EPS(TTM) : 6.28 |
|
Book Value(₹) : 124.49 |
Market Cap(₹Cr) : 1,228.27 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 80.51 | 71.28 | 93.04 | 76.16 | 80.12 | 64.85 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 80.51 | 71.28 | 93.04 | 76.16 | 80.12 | 64.85 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 7.32 | 4.58 | 6.37 | 2.12 | 10.65 | 4.86 |
| Total Income | 87.82 | 75.86 | 99.42 | 78.28 | 90.78 | 69.71 |
| Total Expenditure | 54.36 | 49.05 | 56.08 | 48.25 | 56.63 | 47.82 |
| PBIDT | 33.46 | 26.81 | 43.34 | 30.04 | 34.15 | 21.89 |
| Interest | 4.41 | 4.28 | 4.52 | 4.13 | 4.68 | 4.20 |
| PBDT | 29.05 | 22.53 | 38.82 | 25.91 | 29.47 | 17.68 |
| Depreciation | 20.17 | 17.75 | 17.48 | 15.61 | 11.96 | 8.96 |
| Tax | 2.23 | 1.17 | 6.41 | 2.28 | 3.47 | 2.33 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.12 | 0.03 | -0.79 | 0.41 | 1.12 | -0.08 |
| Reported Profit After Tax | 6.53 | 3.57 | 15.73 | 7.61 | 12.93 | 6.46 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 6.53 | 3.57 | 15.73 | 7.61 | 12.93 | 6.46 |
| EPS (Unit Curr.) | 1.23 | 0.67 | 2.96 | 1.43 | 2.43 | 1.21 |
| EPS (Adj) (Unit Curr.) | 1.23 | 0.67 | 2.96 | 1.43 | 2.43 | 1.21 |
| Calculated EPS (Unit Curr.) | 1.23 | 0.67 | 2.96 | 1.43 | 2.43 | 1.21 |
| Calculated EPS (Adj) (Unit Curr.) | 1.23 | 0.67 | 2.96 | 1.43 | 2.43 | 1.21 |
| Calculated EPS (Ann.) (Unit Curr.) | 4.91 | 2.68 | 11.83 | 5.72 | 9.72 | 4.86 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 4.91 | 2.68 | 11.83 | 5.72 | 9.72 | 4.86 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.64 | 10.64 | 10.64 | 10.64 | 10.64 | 10.64 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 41.56 | 37.61 | 46.58 | 39.44 | 42.62 | 33.75 |
| PBDTM(%) | 36.08 | 31.61 | 41.72 | 34.02 | 36.78 | 27.26 |
| PATM(%) | 8.11 | 5.01 | 16.91 | 9.99 | 16.14 | 9.96 |